Disease-A-Month
Volume 53, Issue 7 , Pages 348-387 , July 2007

Avian Influenza: The Next Pandemic?

References 

  1. Ligon BL. Avian influenza virus H5N1: a review of its history and information regarding its potential to cause the next pandemic. Semin Pediatr Infect Dis. 2005;16:326–335
  2. McFee RB, Bush LM, Boehm KM. Avian influenza: critical considerations for the primary care physician. Johns Hopkins Adv Stud Med. 2006;6(10):431–440
  3. Tuabenberger JK, Reid AH, Lourens RM, et al. Characterization of the 1918 influenza virus polymerase genes. Nature. 2005;4437:889–893
  4. CDC. Information about influenza pandemics. Available at: http://www.cdc.gov/flu/avian/gen-info/pandemics.htm.
  5. WHO. Estimating the impact of the next influenza pandemic: enhancing preparedness. Available at: http://www.who.int/csr/disease/influenza/preparedness2004_12_08/en/index.html.
  6. Tumpey TM, Basler CF, Aguilar PV, et al. Characterization of the reconstructed 1918 Spanish Influenza pandemic virus. Science. 2005;310:77–80
  7. Belshe RB. The origins of pandemic influenza: lessons from the 1918 virus. N Engl J Med. 2005;353(21):2209–2211
  8. WHO. Avian influenza: assessing the pandemic threat. Available at: http://www.who/cds/2005.29.
  9. WHO. Avian influenza (“Bird flu”) and the significance of transmission to humans. Available at: http://www.who.int/mediacentre/factsheets/avian_influenza/en.
  10. Apisarnthanarak A, Kitphati R, Thongphubeth P, et al. Atypical avian influenza (H5N1). Emerging Infect Dis. 2004;10(7):1321–1324
  11. WHO: Ten things you need to know about pandemic influenza. Available at: http://www.who.int/csr/disease/influenza/pandemic10things/en/index.html.
  12. Sidwell RW, Smee DF. Peramivir (BCX-1812, RWJ-270201): potential new therapy for influenza (Expert Opinion). Invest Drug. 2002;11:859–869
  13. Krug RM. The potential use of influenza virus as an agent for bioterrorism. Antiviral Res. 2003;57:147–150
  14. McCaughey B. Saving lives and the bottom line. Modern Healthcare Online. January 30, 2006. Available at: http://www.modernhealthcare.org. Accessed October 31, 2006.
  15. WHO. Confirmed cases of avian influenza to 4/11/07. Available at: http://www.wpro.who.int/sites/csr/data/data_Tables.htm.
  16. WHO. H5N1 avian influenza: timeline of major events. Available at: http://www.who.int/csr/disease/influenza/pandemictimeline/en/index.html.
  17. Bridges CB, Lim W, Hu-Primmer J, et al. Risk of influenza A (H5N1) infection among poultry workers, Hong Kong 1997-1998. J Infect Dis. 2002;185:1005–1010
  18. Saw TA, Lim W, Shortridge K, et al. Isolation of avian influenza A (H5N1) viruses from humans-Hong Kong. MMWR Morb Mortal Wkly Rep. 1997;46:1204–1207
  19. Yuen KY, Wong SSY. Human infection by avian influenza A H5N1. Hong Kong Med J. 2005;11:189–199
  20. Beigel JH, Farrar J, Han AM, et al. Avian influenza A (H5N1) infection in humans. N Engl J Med. 2005;353:1374–1385
  21. US Department of Health and Human Services. PandemicFlu.gov Web site. Available at: http://www.flu.gov/vaccine. Accessed March 7, 2006.
  22. WHO. WHO interim guidelines on clinical management of humans infected by influenza A (H5N1). Available at: http://www.who.int/csr/disease/avian_influenza/guidelines/Guidelines_Clinical%20Management_H5N1_rev.pdf. Accessed October 31, 2006.
  23. Ungchusak K, Auerwarakul P, Dowell SF, et al. Probable person to person transmission of avian influenza A H5N1. N Engl J Med. 2005;352:333–340
  24. Gupta NE. Everything you should know about virulent avian influenza. Cortlandt Forum. 2005;26–34
  25. Tran TH, Nguyen TL, Nguyen TD, et al. World Health Organization International Avian Influenza Investigative team Avian influenza A H5N1 in 10 patients in Vietnam. N Engl J Med. 2004;350:1179–1188
  26. Peiris JS, Yu WC, Leung CW, et al. Re-emergence of fatal human influenza A subtype H5N1 disease. Lancet. 2004;363:617–619
  27. Chotpitayasunondh T, Ungchusak K, Hanshaoworakul W, et al. Human disease from influenza A (H5N1), Thailand, 2005. Emerg Infect Dis. 2005;11:201–209
  28. Tiensin T, Chaitaweesub P, Songserm T, et al. A highly pathogenic avian influenza H5N1, Thailand, 2004. Emerg Infect Dis. 2005;11:1664–1672
  29. deJong MD, Bach VC, Phan TQ, et al. Fatal avian influenza A H5N1 in a child presenting with diarrhea followed by coma. N Engl J Med. 2005;352:686–691
  30. World Health Organization. Epidemiology of WHO-confirmed human cases of avian influenza A (H5N1) infection. Wkly Epidemiol Rec. 2006;81:249–257
  31. U.S. Food and Drug Administration. Flu information. Available at: http://www.fda.gov/oc/opacom/hottopics/flu.html.
  32. National Institutes of Health. Avian flu/pandemic flu. Available at: http://www.nih.gov.
  33. Centers for Disease Control and Prevention. Avian influenza information for physicians. Available at: http://www.cdc.gov/flu.
  34. Heymann DL. SARS and emerging infectious diseases: a challenge to place global solidarity above national sovereignty. Ann Acad Med Singapore. 2006;35:350–353
  35. Heymann DL, Rodier G. Global surveillance, national surveillance and SARS. Emerg Infect Dis. 2004;10:173–175
  36. U.S. Department of Defense Global Emerging Infections Surveillance and Response System (DoD-GEIS). Available at: http://www.geis.fhp.osd.mil/aboutGEIS.asp.
  37. Sims LD, Ellis TM, Liu KK, et al. Avian influenza in Hong Kong 1997–2002. Avian Dis. 2003;47(3):832–838(suppl)
  38. Department of Health, Hong Kong. Letter to doctors on two cases of H5N1 infection in 2004. Available at: http://www.info.gov.hk.dh/useful/ltod/h5n12003.htm.
  39. Snacken R, Kendal AP, Haaheim L, Wood JM. The next influenza pandemic: lessons from Hong Kong. 1997. Emerg Infect Dis. 1999;5:195–203
  40. Wester R, Hulse D. Controlling avian flu at the source. Nature. 2005;435:415–416
  41. Zhou NN, Shortridge KF, Claas ECJ, et al. Rapid evolution of H5N1 influenza viruses in chickens in Hong Kong. J Virol. 1999;73:3366–3374
  42. Fouchier RA, Munster V, Wallensten A, et al. Characterization of a novel influenza A virus hemagglutinin subtype H16 obtained from black headed gulls. J Virol. 2005;79:2814–2822
  43. Govarkova EA, Leneva IA, Galaubeva OG. Comparison of efficacies of RWJ 270201, zanamivir and oseltamivir against H5N1, H9N2 and other avian influenza viruses. Antimicrob Agents Chemother. 2001;45:2723–2732
  44. Madren LK, Shipman C, Hayden FG. In vitro inhibitory effects of combinations of anti-influenza agents. Antivir Chem Chemother. 1995;6:109–113
  45. Taisuke H, Kawaaka Y. Influenza: lessons from past pandemics, warnings from current incidents. Nat Rev Microbiol. 2005;5:591–600
  46. Centers for Disease Control and Prevention. Key facts about influenza vaccine. Available at: http://www.cdc.gov/flu/ protect/keyfacts.htm.
  47. Brown H. Nations set out a global plan for influenza action. Lancet. 2005;12:1684–1685
  48. National Foundation for Infectious Diseases. Improving influenza vaccination rates in health-care workers: strategies to increase protection for workers and patients. Available at: http://www.nfid.org/publications/hcwmonograph.pdf.
  49. Centers for Disease Control and Prevention. Experiences with influenza-like illness and attitudes regarding influenza prevention-United States 2003-2004 influenza season. MMWR Morb Mortal Wkly Rep. 2004;53:1156–1158
  50. Bridges CB, Kuehnert MJ, Hall CB. Transmission of influenza: implications for control in health care settings. Clin Infect Dis. 2003;37:1094–1111
  51. Li KS, Guan Y, Wang J, et al. Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia. Nature. 2004;430:209–213
  52. JEMS. Available at http://www.JEMS.com.
  53. Centers for Disease Control and Prevention. 2004 National immunization survey. Available at: http://www.dshs. state.tx.us/immunize/coverage/nis.shtm.
  54. Liem NT, Lim W. Lack of H5N1 avian influenza transmission to hospital employees. Emerg Infect Dis. 2005;11:210–215
  55. Zigmund J. No more room; overcrowding blamed for ambulance diversions. Modernhealthcare.com. Available at: http://www.modernhealthcare.com/printwindow.cms?articleId=38689&pageType=article.
  56. Webster RG. Wet markets-a continuing source of severe acute respiratory syndrome and influenza?. Lancet. 2004;363:234–236
  57. Bush LM, Abrams BH, Beall A, et al. Index case of fatal inhalation anthrax due to bioterrorism in the United States. N Engl J Med. 2001;345:1607–1610
  58. Smith SM. Where have you been? (The potential to overlook imported disease in the acute setting). Eur J Emerg Med. 2005;12:230–233
  59. Osterholm MT. Emerging infectious diseases: a real public health crisis? Postgraduate Medicine online. Available at: http://www.postgradmed.com/issues/1996/11_96/ed_nov.htm.
  60. Lederberg J, Shope RE, Oaks SC. Emerging Infections: Microbial Threats to Health in the United States. Washington, DC: National Academy Press; 1992;
  61. Stienlauf S, Segal G, Sidi Y, et al. Epidemiology of travel-related hospitalization. J Travel Med. 2005;12:136–141
  62. Chan MC, Cheung CY, Chui WH, et al. Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells. Respir Res. 2005;6:135
  63. Cheung CY, Poon LI, Lau AS, et al. Induction of proinflammatory cytokines in human macrophages by influenza A H5N1 viruses; a mechanism for the unusual severity of human disease?. Lancet. 2002;360:1831–1837
  64. Kunzelmann K, Beesley AH, King NH, et al. Influenza inhibits amiloride-sensitive NA+ channels in respiratory epithelia. Proc Natl Acad Sci USA. 2000;97:10282–10287
  65. Baron S, Isaacs A. Absence of interferon in lungs from fatal cases of influenza. Br Med J. 1962;5270:18–20
  66. Chen XJ, Set S, Yue G, et al. Influenza virus inhibits ENaC and lung fluid clearance. Am J Physiol Lung Cell Mol Physiol. 2004;287:L366–L373
  67. Li KS, Guan Y, Wang J, et al. Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia. Nature. 2004;430:209–213
  68. Ver Herck K, Van Damme P, Castelli F, et al. Knowledge, attitudes and practices in travel-related infectious diseases: the European airport survey. J Travel Med. 2004;11(1):3–8
  69. Chotpitayasunondh T, Lochindarat S, Srisan P, et al. Cases of influenza A (H5N1): Thailand 2004. MMWR Morb Mortal Wkly Rep. 2004;53:100–103
  70. Goldmann DA. Transmission of viral respiratory infections in the home. Pediatr Infect Dis J. 2000;19(10):97S–102S(suppl)
  71. WHO. Responding to the avian influenza pandemic threat. Communicable Disease Surveillance and Response Global Influenza Programme. Available at: http://www.who.int.
  72. Goldmann DA. Epidemiology and prevention of pediatric viral respiratory infections in health care institutions. Emerg Infect Dis. 2001;7:249–253
  73. Hsieh Y, Wu T, Liu D, et al. Influenza pandemics: past, present and future. J Formos Med Assoc. 2006;105:1–6
  74. Yuen KY, Chan PKS, Peiris M, et al. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet. 1998;351:467–471
  75. Chan PKS. Outbreak of avian influenza A (H5N1) virus infection in Hong Kong in 1997. Clin Infect Dis. 2002;34:S58–S64
  76. Reed KD, Melski JW, Graham MB, et al. The detection of monkeypox in humans in the Western Hemisphere. N Engl J Med. 2004;350(4):342–350
  77. Qureshi N. Proceedings of the 2005 annual meeting of the Radiological Society of North America. Available at: http://english.people.com.cn/200512/03eng20051203_225411.html.
  78. Nicholson KG, Wood JM, Zambon M. Influenza. Lancet. 2003;362:1733–1745
  79. Webster R. Predictions for future human influenza pandemics. J Infect Dis. 1997;176(suppl 1):S14–S19
  80. Spackman E, Senne DA, Myers TJ, et al. Development of a real-time reverse transcriptase PCR assay for type A influenza virus and the avian H5 and H7 hemagglutinin subtypes. J Clin Microbiol. 2002;40:3256–3260
  81. Munch M, Nielsen LP, Handberg KJ, et al. Detection and subtyping (H5 and H7) of avian type A influenza virus by reverse transcription PCR and PCR Elisa. ArchVirol. 2001;146:87–97
  82. Lee MS, Change PC, Shien JH, et al. Identification and subtyping of avian influenza viruses by reverse transcription-PCR. J Virol Methods. 2001;97:13–22
  83. Langmuir AD. Changing concepts of airborne infection of acute contagious diseases; a reconsideration of classic epidemiologic theories. In:  Kundsin RB editors. Airborne Contagion. New York, NY: Annals of the New York Academy of Sciences; 1980;p. 35–44
  84. van Riel D, Munster VJ, deWit E, et al. H5N1 virus attachment to lower respiratory tract. Science. 2006;312:399
  85. McFee RB. Preparing for an era of weapons of mass destruction (WMD): are we there yet? (Why we should all be concerned. Part I). Vet Human Tox. 2002;44(4):193–199
  86. deJong MD, Thanh TT, Khanh TH, et al. Oseltamivir resistance during treatment of influenza A (H5N1) infection. N Engl J Med. 2005;353:2667–2672
  87. Canada communicable disease report. June 15, 2006; Volume 32:Issue ACS-7. Available at: http://www.medscape.com/ medline/publicationbrowser/4220/32_ACS-7/dt_06152006/limit_0. Accessed October 31, 2006.
  88. Centers for Disease Control and Prevention. Interim guidance for protection of persons involved in U.S. avian influenza outbreak disease control and eradication activities. Available at: http://www.cdc.gov/flu/avian/professional/protectguid.htm. Accessed October 31, 2006.
  89. L’vov DK, Fediakina IT, Shchelkanov MI, et al. In vitro effects of antiviral drugs on the reproduction of highly pathogenic influenza A/H5N1 virus strains that induce epizooty among poultry in the summer of 2005. Vopr Virusol. 2006;51:20–22
  90. HHS Pursues Advance Development of New Influenza Antiviral Drug. Available at: http://www.hhs.gov/news/press/2007pres/20070104.html.
  91. Peramivir–BioCryst Pharmaceuticals. Available at: http://www.biocryst.com/pdf/peramivirfacts.pdf.
  92. Knight V, Gilbert BE. Ribavirin aerosol treatment of influenza. Infect Dis Clin North Am. 1987;1:441–457
  93. U.S. Food and Drug Administration. Influenza virus vaccine. Available at: http://www.fda.gov/cder/flu/flu.htm.
  94. FDA News 4/16/07: FDA Approves First US Vaccine for Humans Against Avian Influenza Virus H5N1. Available at: http://www.fda.gov/bbs/topics/NEWS/2007/NEW01611.html.
  95. Medical News Today: Sinovac’s Avian Flu Vaccine Development 3 Mar 2007. Available at: http://www.medicalnewstoday.com/printerfriendlynews.php?newsid=20650.
  96. Medical News Today: Focetria Pandemic Influenza Vaccine Receives Positive European Union Regulatory Agency Opinion Supporting Approval. 25 Feb 2007. Available at: http://www.medicalnewstoday.com/printerfriendlynews.pho?newsid=63829.
  97. WHO. Availability of H5N1 prototype strains for influenza pandemic vaccine development. February 2005. Available at: http://www.who.int/csr/disease/avian_influenza/guidelines/avian_influenza_prototype_strain.
  98. Verbiest JP, Castillo CN. Avian flu: an economic assessment for selected developing countries in Asia. ERD Policy Brief No. 24, March 2004. Office of External Relations, Asian Development Bank. Manila, Philippines.
  99. MMWR. Guideline for Hand hygiene in Health-Care Settings. Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. 2002;Vol 51/RR-16 A publication of the CDC
  100. Imported Measles with Subsequent Airborne Transmission in a Pediatrician’s Office, Michigan. MMWR. 1983;32(31):401–403
  101. Bischoff WE, Reynolds TM, Sessler CN, et al. Handwashing compliance by health care workers. Arch Intern Med. 2000;160:1017–1021
  102. Hellekson K. American Association of Pediatricians (AAP) Issues Recommendations on Infection Control in Physicians Offices. Am Fam Physician. 2001;Available at: http://www.aafp.org/afp/20010215/practice.html.
  103. Influenza A (H5N1): WHO interim infection control guidelines for health care facilities 2004. World Health Organization. Available at: http://www.who.int/csr/disease/avian_influenza/guidelines/infectioncontrol1/en/.
  104. Marshall SJ. Governments in a dilemma over bird flu. Bull World Health Organ. 2005;83:325–326
  105. Infectious Diseases Society of America. Available at: http://www.idsociety.org.
  106. Otten M. Public health impact of accelerated measles control in the WHO African Region 2000–2003. Lancet. 2005;366:832–839
  107. Parker AA, Staggs W, Dayan GH, et al. Implications of a 2005 measles outbreak in Indiana for sustained elimination of measles in the United States. N Engl J Med. 2006;355:447–455
  108. Smith S. Measles outbreak shows a global threat; worker from India tied to Hub cases. Boston Globe, June 10, 2006. Available at: http://www.boston.com/news/local/articles/2006/06/10/measles_outbreak_shows_a_global.
  109. Trends in Causes of Death Among the Elderly. Aging Trends No. 1. March 2001. Publication of the Centers for Disease Control and Prevention. National Center for Health Statistics, Atlanta, Georgia.
  110. 2001 Population Reference Bureau. United States Government.
  111. NCHS-FASTATS. Leading causes of death. (Data are for U.S. for year indicated). Number of deaths for leading causes of death. Available at: http://www.cdc.gov/nchs/fastats/lcod.htm. Last accessed May 28, 2006.

PII: S0011-5029(07)00047-8

doi: 10.1016/j.disamonth.2007.05.006

Disease-A-Month
Volume 53, Issue 7 , Pages 348-387 , July 2007

Article Tools

* Image Usage & Resolution